kinase inhibitors (Carna/Sumitomo Dainippon Pharma)

N/A

Report date: 2025/03/20 15:12:10
NME

Base Information

Drug Namekinase inhibitors (Carna/Sumitomo Dainippon Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsMental DisordersNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarna Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarna Biosciences IncSumitomo Chemical Co Ltd
Inactive CompaniesN/A
Active IndicationsMental DisordersNervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A